Why are bio-based chemicals losing market competitiveness despite environmental advantages?

Bio-based chemicals are losing market competitiveness primarily because of a sharp expansion in supply—driven by massive capacity investments in Asia—that has depressed global prices of petrochemical base products, thereby lowering the price floor for all chemicals; as a result, the price premium of bio-based alternatives over conventional petrochemicals has ballooned from 5%–10% to 30%–100%, making them unattractive even to technically mature producers and severely dampening investment appetite. Additionally, the sustainability appeal has waned, policy support remains concentrated on biofuels rather than general bio-based chemicals, and end-consumer demand fails to effectively transmit down the long, complex chemical value chain—leaving cost economics, not environmental benefit, as the decisive factor for market adoption, per S&P Global Commodity Insights.

What are the few promising developments sustaining long-term viability in the bio-based chemical industry?

Despite widespread distress—including bankruptcies of Danimer Scientific, Veridis Chemical, and Nestlé’s renewable chemicals retrenchment—there are grounded signs of resilience: Qore, a joint venture between Cargill and HELM, successfully commissioned a $300 million, 66,000-ton-per-year bio-based 1,4-butanediol plant in Iowa in July 2025 using Genomatica’s commercially validated fermentation technology; this marks the first major new bio-based chemical facility in the U.S. in years and reflects progress through long-term capital commitment, proven tech, and rational planning. Moreover, strategic drivers like supply chain diversification (e.g., Goodyear’s bio-isoprene project) and enduring climate governance imperatives—coupled with rising youth environmental awareness and geopolitical risks to fossil feedstocks—continue to underpin long-term industry relevance, even as firms prioritize short-term survival amid unprecedented market pressure.

Bio-Based Chemical Industry Faces Crisis Amidst High Costs and Market Oversupply

Apr 27, 2026

Bio-based chemical firms face bankruptcy and market pressure due to high costs versus petrochemicals. Despite current struggles, long-term growth persists through sustainability demands and strategic projects like Cargill's new facility.

ccin

2026-04-27

Bio-Based Chemical Industry Faces Crisis Amidst High Costs and Market Oversupply

Bio-Based Chemical Industry Faces Crisis Amidst High Costs and Market Oversupply

FAQ